Thus, it can be determined that AML cells can inhibit the expression of HLA-A by restricting the antigen presentation pathway, thereby avoiding anti-tumor immune responses after the activation of cytotoxic CD8+-T cells. The gene discussed is HLA-A; the disease is neoplasm.